Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Heckman

Showing results (111-120 of 131) with videos related to

Pageof 14
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|October 13, 2022
Phase I Dose Escalation Study of Topical Bexarotene in Women at High Risk for Breast CancerParijatham S Thomas, Anisha B Patel, J Jack Lee, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 3, 2024
A randomized Phase I pre-operative window trial of transdermal endoxifen in women planning mastectomy: Evaluation of dermal safety, intra-mammary drug distribution, and biologic effectsOukseub Lee, Latifa A Bazzi, Yanfei Xu, et al.
Diabetes|October 5, 2019
Metabolite Profiles of Incident Diabetes and Heterogeneity of Treatment Effect in the Diabetes Prevention ProgramZsu-Zsu Chen, Jinxi Liu, Jordan Morningstar, et al.
Journal of the National Cancer Institute|June 13, 2025
Trends in uterine cancer incidence and mortality: insights from a natural history modelWilliam D Hazelton, Matthew Prest, Ling Chen, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 24, 2022
Lessons from the Failure to Complete a Trial of Denosumab in Women With a Pathogenic BRCA1/2 Variant Scheduling Risk-Reducing Salpingo-OophorectomyMeghna S Trivedi, Nadir Arber, Eitan Friedman, et al.
Breast Cancer Research and Treatment|June 12, 2016
Phase I biomarker modulation study of atorvastatin in women at increased risk for breast cancerBanu K Arun, Yun Gong, Diane Liu, et al.
Journal for Immunotherapy of Cancer|May 4, 2026
Safety and immunogenicity of a tri-antigen vaccine targeting IGFBP-2, HER2, and IGF-IR in participants with non-metastatic breast cancerSasha E Stanton, Denise L Cecil, Howard H Bailey, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 1, 2023
Phase II Trial of Nelipepimut-S Peptide Vaccine in Women with Ductal Carcinoma In SituAnne E O'Shea, Guy T Clifton, Na Qiao, et al.
Obstetrics and Gynecology|February 5, 2026
Comparative Modeling of Recent and Projected Trends in the Incidence and Mortality of Uterine CancerKevin J Rouse, William D Hazelton, Axel Frotscher, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 1, 2025
Projected Trends in the Incidence and Mortality of Uterine Cancer in the United StatesJason D Wright, Matthew T Prest, Jennifer S Ferris, et al.
Pageof 14

Showing results (111-120 of 131) with videos related to

Sort By:
Pageof 14
Cancer Prevention Research (Philadelphia, Pa.)|October 13, 2022
Phase I Dose Escalation Study of Topical Bexarotene in Women at High Risk for Breast CancerParijatham S Thomas, Anisha B Patel, J Jack Lee, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 3, 2024
A randomized Phase I pre-operative window trial of transdermal endoxifen in women planning mastectomy: Evaluation of dermal safety, intra-mammary drug distribution, and biologic effectsOukseub Lee, Latifa A Bazzi, Yanfei Xu, et al.
Diabetes|October 5, 2019
Metabolite Profiles of Incident Diabetes and Heterogeneity of Treatment Effect in the Diabetes Prevention ProgramZsu-Zsu Chen, Jinxi Liu, Jordan Morningstar, et al.
Journal of the National Cancer Institute|June 13, 2025
Trends in uterine cancer incidence and mortality: insights from a natural history modelWilliam D Hazelton, Matthew Prest, Ling Chen, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 24, 2022
Lessons from the Failure to Complete a Trial of Denosumab in Women With a Pathogenic BRCA1/2 Variant Scheduling Risk-Reducing Salpingo-OophorectomyMeghna S Trivedi, Nadir Arber, Eitan Friedman, et al.
Breast Cancer Research and Treatment|June 12, 2016
Phase I biomarker modulation study of atorvastatin in women at increased risk for breast cancerBanu K Arun, Yun Gong, Diane Liu, et al.
Journal for Immunotherapy of Cancer|May 4, 2026
Safety and immunogenicity of a tri-antigen vaccine targeting IGFBP-2, HER2, and IGF-IR in participants with non-metastatic breast cancerSasha E Stanton, Denise L Cecil, Howard H Bailey, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 1, 2023
Phase II Trial of Nelipepimut-S Peptide Vaccine in Women with Ductal Carcinoma In SituAnne E O'Shea, Guy T Clifton, Na Qiao, et al.
Obstetrics and Gynecology|February 5, 2026
Comparative Modeling of Recent and Projected Trends in the Incidence and Mortality of Uterine CancerKevin J Rouse, William D Hazelton, Axel Frotscher, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 1, 2025
Projected Trends in the Incidence and Mortality of Uterine Cancer in the United StatesJason D Wright, Matthew T Prest, Jennifer S Ferris, et al.
Pageof 14